BUZZ-<a href="https://laohu8.com/S/POAI">Predictive Oncology</a> rises on exploring strategic alternatives** Shares of cancer therapy developer Predictive Oncology POAI.O rise 4.2% to 82 cents premarket
** Says initiated a process to evaluate a broad range of strategic alternatives and working with an adviser
** Possible alternatives can include a sale of the company, a sale of an asset or assets , or a licensing deal
** Says there can be no assurance that a transaction will occur
** Ended third-quarter with $3.1 mln of cash and cash equivalents, compared to $8.7 mln as of Dec. 31
** Up to last close, stock down 76.1% YTD
(Reporting by Sneha S K)
((Sneha.SK@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments